www.fdanews.com/articles/131550-clinical-data-granted-orphan-drug-designation-for-prx-8066
Clinical Data Granted Orphan Drug Designation for PRX-8066
November 1, 2010
Clinical Data, Inc. Monday announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration has granted Orphan Drug Designation for pulmonary arterial hypertension to PRX-8066, the company’s selective serotonin 2B (5-HT2B) receptor antagonist.
Morningstar
Morningstar